Inside the Minds of Mice And

Total Page:16

File Type:pdf, Size:1020Kb

Inside the Minds of Mice And TECHNOLOGY FEATURE INSIDE THE MINDS OF MICE AND MEN Monitoring technologies and genetic engineering are producing a growing array of animal models for psychiatric disorders, but researchers are still learning how best to use them. SAGE LABS SAGE There is no such thing as an autistic rat, but researchers can study human psychiatric conditions by analysing the behaviour of rodents. BY MONYA BAKER disorder known as fragile X syndrome arises factors from traumatic life experiences to in when humans lack a working copy of the gene utero conditions also contribute. Even when nyone familiar with Rett syndrome FMR1; mice without the gene show learn- researchers have decided which genes or factors will recognize the symptoms. Mouse ing deficits and hyperactivity similar to the to study, it is not always clear how to assess ani- models — animals that carry genetic symptoms of the human disorder. mal models: how can a researcher use a mouse Amutations similar to those that cause the con- But those are conditions with discrete, recog- to study diseases diagnosed by hallucinations or dition in humans — wring their paws, walk nized causes. Other neurocognitive disorders, an inability to understand figurative language? awkwardly and learn poorly. Other human such as autism, depression and schizophrenia, brain disorders have animal models, too. Mice have multiple and often mysterious causes, so FROM BEHAVIOUR TO BIOLOGY with extra copies of the genome regions dupli- mimicking them is more complicated. Studies Craig Powell, a neuro­scientist at the Univer- cated in Down’s syndrome show motor prob- have implicated dozens of genetic variants in sity of Texas Southwestern Medical Center in lems and learning deficits. A developmental producing the disorders, and environmental Dallas, says that the goal of tweaking genes is 7 JULY 2011 | VOL 475 | NATURE | 123 © 2011 Macmillan Publishers Limited. All rights reserved ANIMAL MODELS TECHNOLOGY usually to uncover disease mechanisms. “So you make a mouse with a mutation that you know causes autism in humans, and you see that it has behaviours that resemble autism,” he says. Powell’s next step is to look at slices of the mouse’s brain, to see how it differs from normal mice. At that point, behaviour can help researchers C57BL/6j DBA/2 A/j PHONOMICS B. SPRUIJT/DELTA to home in on what really matters. “We might find a hundred things wrong with the brain function, but only one or two cause changes in behaviour, so we want to fix things and see what changes the behaviour,” says Powell. In work that has become a touchstone for the field, Mark Bear, a neuroscientist at the Massachusetts Institute of Technology (MIT) in Cambridge, and his colleagues showed that reducing expres- Balb/c 129S1/Sv C3H sion of a particular receptor in mice ameliorated Video tracking of different mouse strains (labelled) reveals that some explore a new cage more than others. the effects of a mutation that causes fragile X syndrome1. Several physiological abnormalities autism and developmental disorders. Tests wrong with their skin: open sores appeared were reversed, and engineered mice had fewer on the offspring showed that the sympto- on their faces. After tests showed nothing seizures and better memories. matic behaviours recurred in only some of the abnormal, video surveillance revealed that In another example, Adrian Bird, a geneticist genetic backgrounds. In another study5, mice the mice groomed themselves excessively, at the Wellcome Trust Centre for Cell Biology from a strain displaying a range of autism- literally rubbing through their fur. Further in Edinburgh, UK, and his colleagues reversed relevant symptoms were reared by and with work showed abnormalities in a region of the symptoms resembling Rett syndrome in mice2. mice from a strain known for high sociability. brain linked to obsessive–compulsive disorder They crafted a version of the defective gene The fostered mice showed no social deficits as (OCD). Although SAPAP3 had not previously that could be restored to normal activity with a adults, but other relevant symptoms, such as been implicated in the condition, drugs that supplement to a mouse’s diet, but administered repetitive grooming, were not reduced. And eased OCD symptoms in humans reduced the the supplement only after mice carrying the when a mutant version of DISC1, the first gene grooming in mice. gene began to exhibit symptoms. Activating to be implicated in schizophrenia, is present Studies8 of proteins the gene at this point was expected to have little in mice whose mother’s immune system has that interact with effect, but the mice showed marked improve- been stressed during pregnancy, the offspring SAPAP3 revealed that ment, raising hopes that recovery might also exhibit symptoms of affective disorders and they, too, had links to be possible in humans. A similar study3 into autism6. Without the environmental stressors, OCD and autism. spinal muscular atrophy found that restor- they show symptoms of schizophrenia. As human genetic ing a defective gene’s function four days after studies reveal gene birth essentially eliminated signs of the disease; HIDDEN SYMPTOMS variants with increas- doing so ten days after birth had little effect. Even the cleverest assays cannot capture some ingly smaller impacts Such studies could help researchers to predict important aspects of human disease, such as the on disease, there is which patients are most likely to benefit in paranoid delusions common in schizophrenia. “When in increasing demand clinical trials. (In fact, because the models will always be doubt, the for new behavioural Research into behaviour can also probe imperfect, most behavioural researchers object experimenter tests to assess them. how genetic variants interact with each other to phrases such as ‘schizophrenic mice’.) Mikhail needs to look at Results of assays are and with environmental factors. In one study Pletnikov, a neuro­behaviourologist at Johns what the animal highly variable, and published this year4, wild-type males from five Hopkins University in Baltimore, Maryland, is is doing.” they may not measure mouse strains were bred with females carrying one of many scientists hoping to complement Douglas Wahlsten the most meaning- C. TOUMA/MAX PLANCK INST. PSYCH. PLANCK INST. C. TOUMA/MAX a mutation that causes symptoms resembling behavioural tests with more readily measured ful symptoms, says biomarkers. People with schizophrenia exhibit Jeffrey Mogil, a neuro­scientist at McGill Uni- a wide range of behavioural symptoms, but their versity in Montreal, Canada. “We’ve made a lot lateral ventricles — fluid-filled cavities on either of advances in making ever-fancier mice, but at side of the brain — tend to be larger than aver- the end of the day the question is, what’s your age, so Pletnikov is using brain scans to measure assay and what’s your measure and are they these structures in mice. It is not always nec- relevant?” he says. “The slow link in the chain, essary to see a behavioural change to probe a the messy link in the chain, has always been the diease’s biology, he says. “With humility, you can behavioural assays.” use mice or rats or even worms.” Current tests of animal behaviour are Unexpected behaviours have revealed unan- blunt tools. The Morris water-navigation ticipated biology. Several years ago, Guoping task evaluates an animal’s cognitive ability by Feng, a neuroscientist now at MIT, was trying assessing how it learns to use spatial cues to to work out the function of various proteins swim to an underwater platform that it can’t found on either side of the synapses that con- see. Changes in the animal’s performance can nect neurons. Knocking out one such protein, be used to measure learning and memory. SAPAP3, had no apparent effect on brain func- Tests for anxiety include the open-field test, tion: the mice walked and learned normally7. which measures the time a mouse spends in Less-anxious mice spend longer in open spaces. They did, however, seem to have something enclosed spaces or along the edges of its cage; 7 JULY 2011 | VOL 475 | NATURE | 125 © 2011 Macmillan Publishers Limited. All rights reserved TECHNOLOGY ANIMAL MODELS nervous animals avoid exposed areas. For both, of children without autism playing together psychiatric drugs effective in humans change and the ones with autism being off to the side, the outcomes. playing with a train or a computer,” she recalls. Such tests can be effective at screening new So Crawley designed a task that would assess drugs that act by the same mechanisms as whether a mouse chose to spend time with existing ones. But they are less useful for con- a social partner or an inanimate object. The ditions for which no effective drugs exist, or for assay is now used in many laboratories. gaining insight into pathology. So researchers Clinical tests have inspired other animal are trying to develop tests that capture more- counterparts. Mogil and his colleagues pro- specific components of human disorders. duced the mouse-grimace scale for pain “We talk more to the clinical researchers,” says assessment9, based on a scale that used facial Jacqueline Crawley, chief of behavioural neuro- expressions to determine pain in infants and science at the US National Institute of Mental other humans incapable of speaking. Mogil NORTH CAROLINA GREENSBORO D. WAHLSTEN/UNIV. Health in Bethesda, believes his scale will prove a more reliable The colours of mice and their bedding can confuse Maryland. “There are measure of chronic pain than commonly used video-tracking systems. opportunities for us assays such as the tail-flick test, which meas- to sit down and say, ures how quickly a mouse moves its tail out of mouse models of autism. ‘what do these dis- a beam of light. It should also help researchers Tim Bussey and Lisa Saksida, neuro­scientists eases look like, what to design more-humane experiments.
Recommended publications
  • Reproducibility of Behavioral Phenotypes in Mouse Models - a Short History with Critical and Practical Notes
    Reproducibility of behavioral phenotypes in mouse models - a short history with critical and practical notes Vootele Voikar Neuroscience Center and Laboratory Animal Center, Helsinki Institute of Life Science Correspondence: Mustialankatu 1 G Helsinki, Finland [email protected] Progress in pre-clinical research is built on endorsed by more than 1000 journals so far, reproducible findings, yet reproducibility has awareness of researchers and the quality of different dimensions and even meanings. Indeed, publications have not been sufficiently improved the terms reproducibility, repeatability, and (13-15). In order to facilitate and enhance replicability are often used interchangeably, implementation of the ARRIVE guidelines, a although each has a distinct definition. Moreover, revised version with exhaustive explanation and reproducibility can be discussed at the level of elaborative documentation was recently published methods, analysis, results, or conclusions (1, 2). (16, 17). Despite these differences in definitions and Paradigm shift. Mice and rats are the most dimensions, the main aim for an individual widely used model animals in basic biomedicine. research group is the ability to develop new However, there has been a drastic change in the studies and hypotheses based on firm and reliable relative use of these two rodent species over time findings from previous experiments. In practice (Figure 1). Historically, the rat was the model of this wish is often difficult to accomplish. In this choice for behavioral studies but from the review, issues affecting reproducibility in the field beginning of 1990s a sharp shift from rats to mice of mouse behavioral phenotyping are discussed. took place. Obviously, this was due to rapid Crisis in reproducibility.
    [Show full text]
  • 56Th Annual Teratology Society Meeting
    54th Annual Meeting Birth Defects Research (Part A) 106:309–347 (2016) This event has been accredited by the McGill Center for Continuing Health Professional Education. 29th Annual Meeting for Organization of the Teratology Information Specialists (OTIS) June 25–28, 2016 40th Annual Meeting of the Developmental Neurotoxicology Society (DNTS) June 26–29, 2016 All text and graphics are © 2016 by the Teratology Society unless noted. River Walk photo courtesy of Staurt Dee/SACVB. Birth Defects Research (Part A) Clinical and Molecular Teratology 106:309–347 (2016) 310 TERATOLOGY SOCIETY PROGRAM Birth Defects Research (Part A) 106:309–347 (2016) TERATOLOGY SOCIETY PROGRAM 311 Program & Abstracts New Horizons in Birth Defects Research All text and graphics are © 2016 by the Teratology Society unless noted. River Walk photo courtesy of Staurt Dee/SACVB. Birth Defects Research (Part A) 106:309–347 (2016) 312 TERATOLOGY SOCIETY PROGRAM Program Overview FRIDAY, JUNE 24, 2016 12:00 Noon–1:30 PM 12:00 Noon–1:30 PM WEDNESDAY, JUNE 29, 2016 3:00 PM–6:00 PM Student and Postdoctoral Fellow Past Presidents’ and Honorees’ 6:30 AM–7:30 AM Council 1A Meeting Lunch Workshop Luncheon (By Invitation Only) Teratology Society 35th Annual Advancing Your Career in Birth Defects 3:00 PM–6:00 PM 1:30 PM–5:30 PM Volleyball Game Research and Prevention March of Dimes Symposium Registration Open (Advance Registration Required) 7:00 AM–2:30 PM New Approaches to the Treatment of Registration Open 3:00 PM–6:00 PM 1:30 PM–2:00 PM Birth Defects Speaker Ready Room Open 7:00 AM–2:30 PM F.
    [Show full text]
  • The Developmental Neurobiology of Autism Spectrum Disorder
    The Journal of Neuroscience, June 28, 2006 • 26(26):6897–6906 • 6897 Mini-Review Editor’s Note: Two reviews in this week’s issue examine the rapidly expanding interest in autism research in the neuroscience community. Moldin et al. provide a brief prospective on the overall state of research in autism. DiCicco-Bloom and colleagues summarize their presentations at the Neurobiology of Disease workshop at the 2005 Annual Meeting of the Society for Neuroscience. The Developmental Neurobiology of Autism Spectrum Disorder Emanuel DiCicco-Bloom,1 Catherine Lord,2 Lonnie Zwaigenbaum,3 Eric Courchesne,4,5 Stephen R. Dager,6 Christoph Schmitz,7 Robert T. Schultz,8 Jacqueline Crawley,9 and Larry J. Young10 1Departments of Neuroscience and Cell Biology and Pediatrics (Neurology), Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, 2University of Michigan Autism and Communication Disorders Center, Departments of Psychology and Psychiatry, University of Michigan, Ann Arbor, MI 48109-2054, 3Department of Pediatrics, McMaster University, Hamilton, Ontario, L8N 3Z5, Canada, 4Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, 5Center for Autism Research, Children’s Hospital Research Center, San Diego, California 92123, 6Departments of Radiology, Psychiatry, and Bioengineering, University of Washington School of Medicine, Seattle, Washington 98105, 7Department of Psychiatry and Neuropsychology, Division of Cellular Neuroscience, Maastricht University,
    [Show full text]
  • 2008 Program
    International Behavioral Neuroscience Society Annual Meeting Program and Abstracts St. Thomas, US Virgin Islands June 17-21, 2008 Abstracts of the International Behavioral Neuroscience Society, Volume 17, June 2008 TABLE OF CONTENTS Abstracts....................................................................................................................... 29-88 Acknowledgments................................................................................................................5 Call for 2009 Symposium Proposals....................................................................................9 Advertisements............................................................................................................. 93-99 Author Index ................................................................................................................ 89-92 Exhibitors/Sponsors .............................................................................................................4 Future Meetings...................................................................................................Back Cover Officers/Council...................................................................................................................2 Program/Schedule ........................................................................................................ 10-28 Summary Program ...................................................................................Inside Back Cover Travel Awards......................................................................................................................3
    [Show full text]
  • Jacqueline N. Crawley, Ph.D
    Jacqueline N. Crawley, Ph.D. Clinical Interests Jacqueline N. Crawley, Ph.D., is an internationally recognized leader in behavioral neuroscience, mouse behavioral genetics, and translational neuropharmacology. Dr. Crawley joined the University of California Davis in July 2012 as the Robert E. Chason Endowed Chair in Translational Research at the MIND Institute and Professor in Residence in the Department of Psychiatry and Behavioral Sciences at the UC Davis School of Medicine. Her research program focuses on rodent models of neuropsychiatric disorders. Current emphasis is on understanding the genetic causes of autism spectrum disorders, and discovering effective medical therapeutics for the core diagnostic symptoms of autism. Mouse models are used as preclinical research tools to test hypotheses about the etiology of autism and to evaluate the therapeutic benefit of proposed treatment interventions. Dr. Crawley received her B.A. in biology from the University of Pennsylvania, Ph.D. in zoology from the University of Maryland, and conducted postdoctoral research in neuropsychopharmacology at Yale University School of Medicine. As an intramural investigator in the National Institute of Mental Health Intramural Research Program in Bethesda, Maryland from 1983 to 2012, she served as Chief of the Laboratory of Behavioral Neuroscience. Her laboratory has published over 260 papers and 100 reviews. She serves on 16 journal editorial boards and numerous scientific advisory committees. Honors include the Distinguished Scientist Award from the International Behavioral and Neural Genetics Society, Myers Lifetime Achievement Award from the International Behavioral Neuroscience Society, Society for Neuroscience Service Award, Fleur Strand Lecture Award from the Summer Neuropeptide Conference, Gladstone Institute of Neurological Disease Distinguished Scholar Award, MIND Institute Distinguished Lecturer, Mathilde Solowey Lecture Award in Neuroscience, NIMH Director’s Award, and Howard Hughes Medical Research Institute Preceptor Award.
    [Show full text]
  • Ibangs 2021: Genes, Brain and Behavior 2021
    6/4/2021 TRAINEE SYMPOSIUM ITINERARY IBANGS 2021: GENES, BRAIN AND BEHAVIOR 2021 SPONSORS TRAINEE SYMPOSIUM MACHINE LEARNING WORKSHOP POSTER MAP PROGRAM AUTHORS KEYWORDS SLIDES TRAINEE SYMPOSIUM ITINERARY First Annual IBANGS Trainee Symposium on Monday, May 10th at 11am EDT 11:00am-11:15am Welcome 11:15am-12:15pm Science Grant Panel: Dr. Anna-Lisa Lucido, Director, Research Program Development, Jackson Laboratory Dr. Lisa Tarantino, Associate Professor, University of Carolina at Chapel Hill Dr. Amy Lasek, Associate Professor, University of Chicago at Illinois Dr. Marina Guizetti, Professor, Oregon Health and Science University 12:15pm-13:15pm Trainee Talks: 12:15pm: Dr. Ana Filošević Vujnović, Postdoctoral Fellow, University of Rijeka 12:30pm: Julie Sadino, Graduate Student, University of Colorado, Boulder 12:45pm: Miriam Menken, Graduate Student, University of Maryland, Baltimore 13:00pm-13:15pm Data Blitz Saeedeh Hosseinian, Graduate Student, Queen Mary University of London Hayley Thorpe, Graduate Student, University of Guelph https://easychair.org/smart-program/IBANGS2021/traineesymp.html 1/3 6/4/2021 TRAINEE SYMPOSIUM ITINERARY 13:15-13:30pm Break in Walkabout 13:30pm-14:30pm Trainee Talks: 13:30pm: Lucy Hall, Graduate Student, University of Colorado, Boulder 13:45pm: Antonios Diab, Postdoctoral Fellow, Dalhousie University 14:00pm-14:15pm Data Blitz Elam Cutts, Post baccalaureate Student, University of Alabama, Birmingham Elizabeth Brown, Postdoctoral Fellow, Florida Atlantic University Jacob Beierle, Graduate Student, Boston University 14:15-14:30pm Break in Walkabout 14:30pm-15:30pm Science Career Panel: Dr. George Inglis, Communications Biology Editor Dr. Sadie Nennig, Medical Science Liaison, Bristol Meyers Squibb Dr. Megan Mulligan, Assistant Professor, University of Tennessee Health Science Center Dr.
    [Show full text]
  • 9Th Annual International Meeting for Autism Research (IMFAR)
    99thth AAnnualnnual IInternationalnternational MMeetingeeting FForor AAutismutism RResearchesearch ((IMFAR)IMFAR) PPhiladelphiahiladelphia • MMayay 220-22,0-22, 22010010 Program Thursday May 20th 6:30-5:00P Registration (Registration Grand Ballroom Pre-Function Lvl 5) 7:15-8:15A Coffee and Pastries (Grand Ballroom Pre-Function Lvl 5) 8:15-8:30A Greetings from the IMFAR organizers (Grand Ballroom AF Lvl 5) 8:30-9:30A Keynote: Jacqueline Crawley: “Mouse Models of Autism to Discover Causes and Develop Treatments” 8:00-1:00P Poster & Exhibits 9:30-10:00A Break (Franklin Hall B Lvl 4) (Franklin Hall B 10:00-12:00P IES: Neuro-Imaging Genetics (Grand Ballroom F Lvl 5) Lvl 4) Oral Session: Cognition 1 Oral Session: Epidemiology 1 (Grand Ballroom AB Oral Session: Treatment 1 Social Function, 10:00-12:00P (Grand Ballroom CD Lvl 5) Lvl 5) (Grand Ballroom E Lvl 5) Communication, Sensory Systems, 12:00-1:15P Lunch Break Developmental SIG: EEG & MEG Stages, Language, SIG: Postmortem Brain Research SIG: Sleep and Autism 12:15-1:15P (Grand Ballroom AB Lvl 5) Imitation & Play (Grand Ballroom CD Lvl 5) (Grand Ballroom E Lvl 5) 1:30-3:30P IES: The Ethics of Communicating Scientifi c Risk (Grand Ballroom F Lvl 5) 1:00-5:30P Posters Oral Session: Communication & Language Oral Session: Neurophysiology (Grand Ballroom AB Oral Session: Brain Imaging 1 (Grand Ballroom & Exhibits 1:30-3:30P (Grand Ballroom CD Lvl 5) Lvl 5) E Lvl 5) (Franklin Hall B Lvl 4) 3:30-4:00P Break (Franklin Hall B Lvl 4) Social Function, 4:00-4:30P Tom Insel: IACC Update: (Grand Ballroom AF Lvl 5) Developmental Stages, Treatment, Lifetime Achievement Award and Presentations (Grand Ballroom AF Lvl 5) 4:30-6:00P Clinical Phenotype & Edward R.
    [Show full text]
  • International Behavioral Neuroscience Society Program/Abstracts
    International Behavioral Neuroscience Society Program/Abstracts June 16-20, 2004 Key West, Florida, USA Abstracts of the International Behavioral Neuroscience Society, Volume 13, June 2004 OFFICERS President ..........................................................................................................Robert J. Blanchard President-Elect .......................................................................................................... C. Sue Carter Immediate Past-Pres. ..............................................................................................Mark A. Geyer Past-President...........................................................................................................John P. Bruno Secretary ...........................................................................................................Paula J. Geiselman Treasurer..............................................................................................................Nancy Ostrowski Past Presidents Jacqueline N. Crawley.............................................................................................................2000 László Lénárd ...........................................................................................................................1999 Robert L. Isaacson ...................................................................................................................1998 Michael L. Woodruff ...............................................................................................................1997
    [Show full text]
  • UNIVERSITY of CALIFORNIA, IRVINE Endocannabinoid Signaling
    UNIVERSITY OF CALIFORNIA, IRVINE Endocannabinoid signaling in social behavior DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biomedical Science by Don Wei Dissertation Committee: Professor Daniele Piomelli, Chair Professor Christine Gall Professor James McGaugh Professor Fred Ehlert 2016 © 2016 Don Wei DEDICATION To family and friends my dear parents to my love Christine in recognition of their unconditional support The lesson from childhood, then, is that if you want to win the war for attention, don’t try to say ‘no’ to the trivial distractions you find on the information smorgasbord; try to say ‘yes’ to the subject that arouses a terrifying longing, and let the terrifying longing crowd out everything else. David Brooks -- We must not cease from exploration. At the end of all our exploring will be to arrive where we began and to know the place for the very first time. TS Eliot ii TABLE OF CONTENTS Page LIST OF FIGURES iv ACKNOWLEDGMENTS v CURRICULUM VITAE vi ABSTRACT OF THE DISSERTATION ix CHAPTER 1: General Introduction 1 CHAPTER 2: Endocannabinoid signaling mediates oxytocin-driven social reward 17 CHAPTER 3: A role for 2-AG in social and high-fat food reward in mice 43 CHAPTER 4: Enhancement of anandamide-mediated endocannabinoid 67 signaling corrects autism-related social impairment CHAPTER 5: Adolescent cannabinoid exposure persistently impairs social reward 87 CHAPTER 6: Endocannabinoid signaling mediates social protection against pain 93 CHAPTER 7: General Discussion 98 iii LIST OF FIGURES Page CHAPTER 2: Endocannabinoid signaling mediates oxytocin-driven social reward Figure 2.1: Anandamide signaling at CB1 receptors mediates social reward 21 Figure 2.2: Oxytocin transmission enhances anandamide mobilization 23 in the nucleus accumbens Figure 2.3 3: Anandamide mediates oxytocin-dependent social reward 25 Supplementary Fig.
    [Show full text]
  • 17Th Annual Genes, Brain & Behaviour Meeting Evolutionary
    17th Annual Genes, Brain & Behaviour Meeting Evolutionary Biology Centre Uppsala University, Sweden May 19 – 22, 2015 Genes, Brain, and Behavior 2015 17th Annual Meeting of the International Behavioural and Neural Genetics Society May 19 – 22, 2015 Uppsala, Sweden Page index Organizers 4 Sponsors IBANGS 2015 5 Travel Awardees 2015 6 Program overview 7 Meeting program in detail 8 Conference Information 15 Maps 17 Talk Abstracts 19 Poster Abstracts 41 Save the Date! Genes, Brain and Behavior 2016 Bar Harbor, Maine, USA. May 13-17, 2016 Local Host: Elissa Chesler Genes, Brain, and Behavior 2015 3 Organizers Local Hosts and Organizing Committee Lina Emilsson Petronella Kettunen Elena Jazin Program Committee Lina Emilsson Steve Boehm Lisa Tarantino Marissa Ehringer Chen Gang Karl Clark Chris Kliethermes Elissa Chesler Awards Committee Mary-Anne Enoch (2014-2016, Chair) Jacqueline Crawley (2012-2014) Stephen Boehm (2012-2014) Maria Luisa Scattoni (2013-2015) Josh Dubnau (2014-2015) Marissa Ehringer (2014-2016) Robert Gerlai (2014-2016) IBANGS Central Office Marianne Van Wagner, Executive Coordinator Alison Watson, MBA, DES, Business & Event Manager 1123 Comanche Path Bandera, TX 78003-4212 Phone: 830-796-9393 Fax: 830-796-9394 Toll-free from within the US: 866-377-4416 Email: [email protected] Visit us on the web: www.ibangs.org Genes, Brain, and Behavior 2015 4 Sponsors IBANGS 2015 With generous support from: National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 9000 Rockville Pike Bethesda, Maryland, USA 20892
    [Show full text]
  • Disciplinary Divides and Experimental Skill in Animal Behaviour Genetics
    Med. Hist. (2015), vol. 59(3), pp. 465–485. c The Author 2015. Published by Cambridge University Press 2015 doi:10.1017/mdh.2015.30 A Knockout Experiment: Disciplinary Divides and Experimental Skill in Animal Behaviour Genetics NICOLE C. NELSON* Department of the History of Science, University of Wisconsin – Madison, 1225 Linden Drive, Madison, WI 53706, USA Abstract: In the early 1990s, a set of new techniques for manipulating mouse DNA allowed researchers to ‘knock out’ specific genes and observe the effects of removing them on a live mouse. In animal behaviour genetics, questions about how to deploy these techniques to study the molecular basis of behaviour became quite controversial, with a number of key methodological issues dissecting the interdisciplinary research field along disciplinary lines. This paper examines debates that took place during the 1990s between a predominately North American group of molecular biologists and animal behaviourists around how to design, conduct, and interpret behavioural knockout experiments. Drawing from and extending Harry Collins’s work on how research communities negotiate what counts as a ‘well-done experiment,’ I argue that the positions practitioners took on questions of experimental skill reflected not only the experimental traditions they were trained in but also their differing ontological and epistemological commitments. Different assumptions about the nature of gene action, eg., were tied to different positions in the knockout mouse debates on how to implement experimental controls. I conclude by showing that examining representations of skill in the context of a community’s knowledge commitments sheds light on some of the contradictory ways in which contemporary animal behaviour geneticists talk about their own laboratory work as a highly skilled endeavour that also could be mechanised, as easy to perform and yet difficult to perform well.
    [Show full text]
  • Jacqueline N. Crawley, Ph.D
    March 2021 CURRICULUM VITA Jacqueline N. Crawley, Ph.D. Distinguished Professor Emeritus MIND Institute Department of Psychiatry and Behavioral Sciences University of California Davis School of Medicine Room 1001A Research II Building 96 4625 2nd Avenue Sacramento, CA 95817 [email protected] EDUCATION 1967-71 B.A., Biology, University of Pennsylvania, Philadelphia, PA 1971-76 Ph.D., Zoology, University of Maryland, College Park, MD 1976-79 Postdoctoral, Neuropsychopharmacology, Yale University School of Medicine, New Haven, CT PROFESSIONAL EMPLOYMENT 2020 – present Distinguished Professor Emeritus, MIND Institute Department of Psychiatry and Behavioral Sciences University of California Davis School of Medicine 2012-2020 Robert E. Chason Endowed Chair in Translational Research, MIND Institute Distinguished Professor, Department of Psychiatry and Behavioral Sciences University of California Davis School of Medicine 2003-2012 Chief, Laboratory on Behavioral Neuroscience Intramural Research Program, National Institute of Mental Health, Bethesda, MD 1996-Present Adjunct Professor, Department of Pharmacology Georgetown University School of Medicine, Washington, DC 2003-2008 Adjunct Professor, Department of Psychiatry Research Professor, Department of Psychology University of North Carolina School of Medicine at Chapel Hill 2001-2003 Chief, Section on Behavioral Genomics IRP, National Institute of Mental Health, Bethesda, MD 1993-2000 Chief, Section on Behavioral Neuropharmacology Experimental Therapeutics Branch, Intramural Research Program National Institute of Mental Health, Bethesda, MD 1993-94 Acting Deputy Director, Intramural Research Program National Institute of Mental Health, Bethesda, MD 1983-93 Chief, Unit on Behavioral Neuropharmacology, Tenured 1988 Clinical Neuroscience Branch/Experimental Therapeutics Branch National Institute of Mental Health, Bethesda, MD 1981-83 Senior Neurobiologist, Central Research and Development E.I.
    [Show full text]